Related Experiment Video
Updated: Aug 17, 2025
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
Extracorporeal Membrane Oxygenation for Graft Dysfunction Early After Heart Transplantation: A Systematic Review and
Natasha Aleksova1, Tayler A Buchan1, Farid Foroutan1
1Women's College Hospital, Peter Munk Cardiac Centre, Toronto General Hospital, Toronto, Ontario, Canada.
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is used for severe graft dysfunction after heart transplant (HT). One-third of patients die within 30 days, and half die within one year, highlighting the need for improved VA-ECMO strategies.
Area of Science:
- Cardiology
- Transplantation Medicine
- Critical Care Medicine
Background:
- Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is a key treatment for severe early graft dysfunction following heart transplantation (HT).
- Optimizing VA-ECMO strategies is crucial for improving patient outcomes after HT.
Conclusions:
- One-third of patients undergoing VA-ECMO for early graft dysfunction do not survive 30 days or hospital discharge.
- Half of heart transplant recipients supported by VA-ECMO do not survive to the 1-year mark.
- Further research is essential to refine VA-ECMO strategies and post-transplant care to enhance survival rates.
More Related Videos
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
06:22Author Spotlight: Advancing Cardiovascular Research — Tailored Langendorff Perfusion Techniques for Improved Experimental Outcomes
Published on: June 14, 2024